List of Tables
Table 1. Global Long-acting Hormone Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Long-acting Hormone Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Long-acting Hormone Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Long-acting Hormone Injection Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Long-acting Hormone Injection Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Long-acting Hormone Injection Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Long-acting Hormone Injection Sales by Region (2020-2025) & (K Units)
Table 8. Global Long-acting Hormone Injection Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Long-acting Hormone Injection Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Long-acting Hormone Injection Sales Share by Manufacturers (2020-2025)
Table 12. Global Long-acting Hormone Injection Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Long-acting Hormone Injection Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Long-acting Hormone Injection by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Hormone Injection as of 2024)
Table 16. Global Long-acting Hormone Injection Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Long-acting Hormone Injection Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Long-acting Hormone Injection Manufacturing Base and Headquarters
Table 19. Global Long-acting Hormone Injection Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Long-acting Hormone Injection Sales by Type (2020-2025) & (K Units)
Table 23. Global Long-acting Hormone Injection Sales by Type (2026-2031) & (K Units)
Table 24. Global Long-acting Hormone Injection Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Long-acting Hormone Injection Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Long-acting Hormone Injection ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Long-acting Hormone Injection Sales by Application (2020-2025) & (K Units)
Table 29. Global Long-acting Hormone Injection Sales by Application (2026-2031) & (K Units)
Table 30. Long-acting Hormone Injection High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Long-acting Hormone Injection Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Long-acting Hormone Injection Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Long-acting Hormone Injection ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Long-acting Hormone Injection Growth Accelerators and Market Barriers
Table 37. North America Long-acting Hormone Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Long-acting Hormone Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Long-acting Hormone Injection Growth Accelerators and Market Barriers
Table 40. Europe Long-acting Hormone Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Long-acting Hormone Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Long-acting Hormone Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Long-acting Hormone Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Long-acting Hormone Injection Growth Accelerators and Market Barriers
Table 45. Southeast Asia Long-acting Hormone Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Long-acting Hormone Injection Investment Opportunities and Key Challenges
Table 47. Central and South America Long-acting Hormone Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Long-acting Hormone Injection Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Long-acting Hormone Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Pfizer Corporation Information
Table 51. Pfizer Description and Major Businesses
Table 52. Pfizer Product Models, Descriptions and Specifications
Table 53. Pfizer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Pfizer Sales Value Proportion by Product in 2024
Table 55. Pfizer Sales Value Proportion by Application in 2024
Table 56. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 57. Pfizer Long-acting Hormone Injection SWOT Analysis
Table 58. Pfizer Recent Developments
Table 59. Bayer Corporation Information
Table 60. Bayer Description and Major Businesses
Table 61. Bayer Product Models, Descriptions and Specifications
Table 62. Bayer Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Bayer Sales Value Proportion by Product in 2024
Table 64. Bayer Sales Value Proportion by Application in 2024
Table 65. Bayer Sales Value Proportion by Geographic Area in 2024
Table 66. Bayer Long-acting Hormone Injection SWOT Analysis
Table 67. Bayer Recent Developments
Table 68. Organon Corporation Information
Table 69. Organon Description and Major Businesses
Table 70. Organon Product Models, Descriptions and Specifications
Table 71. Organon Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Organon Sales Value Proportion by Product in 2024
Table 73. Organon Sales Value Proportion by Application in 2024
Table 74. Organon Sales Value Proportion by Geographic Area in 2024
Table 75. Organon Long-acting Hormone Injection SWOT Analysis
Table 76. Organon Recent Developments
Table 77. Merck & Co. Inc. Corporation Information
Table 78. Merck & Co. Inc. Description and Major Businesses
Table 79. Merck & Co. Inc. Product Models, Descriptions and Specifications
Table 80. Merck & Co. Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Merck & Co. Inc. Sales Value Proportion by Product in 2024
Table 82. Merck & Co. Inc. Sales Value Proportion by Application in 2024
Table 83. Merck & Co. Inc. Sales Value Proportion by Geographic Area in 2024
Table 84. Merck & Co. Inc. Long-acting Hormone Injection SWOT Analysis
Table 85. Merck & Co. Inc. Recent Developments
Table 86. Adare Pharma Solutions Corporation Information
Table 87. Adare Pharma Solutions Description and Major Businesses
Table 88. Adare Pharma Solutions Product Models, Descriptions and Specifications
Table 89. Adare Pharma Solutions Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Adare Pharma Solutions Sales Value Proportion by Product in 2024
Table 91. Adare Pharma Solutions Sales Value Proportion by Application in 2024
Table 92. Adare Pharma Solutions Sales Value Proportion by Geographic Area in 2024
Table 93. Adare Pharma Solutions Long-acting Hormone Injection SWOT Analysis
Table 94. Adare Pharma Solutions Recent Developments
Table 95. Mylan NV Corporation Information
Table 96. Mylan NV Description and Major Businesses
Table 97. Mylan NV Product Models, Descriptions and Specifications
Table 98. Mylan NV Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Mylan NV Recent Developments
Table 100. Novo Nordisk Corporation Information
Table 101. Novo Nordisk Description and Major Businesses
Table 102. Novo Nordisk Product Models, Descriptions and Specifications
Table 103. Novo Nordisk Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Novo Nordisk Recent Developments
Table 105. Genentech Corporation Information
Table 106. Genentech Description and Major Businesses
Table 107. Genentech Product Models, Descriptions and Specifications
Table 108. Genentech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. Genentech Recent Developments
Table 110. Eli Lily Corporation Information
Table 111. Eli Lily Description and Major Businesses
Table 112. Eli Lily Product Models, Descriptions and Specifications
Table 113. Eli Lily Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Eli Lily Recent Developments
Table 115. Shree Venkatesh International Limited Corporation Information
Table 116. Shree Venkatesh International Limited Description and Major Businesses
Table 117. Shree Venkatesh International Limited Product Models, Descriptions and Specifications
Table 118. Shree Venkatesh International Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. Shree Venkatesh International Limited Recent Developments
Table 120. LG Chem Corporation Information
Table 121. LG Chem Description and Major Businesses
Table 122. LG Chem Product Models, Descriptions and Specifications
Table 123. LG Chem Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. LG Chem Recent Developments
Table 125. Anhui Anke Biotechnology Corporation Information
Table 126. Anhui Anke Biotechnology Description and Major Businesses
Table 127. Anhui Anke Biotechnology Product Models, Descriptions and Specifications
Table 128. Anhui Anke Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Anhui Anke Biotechnology Recent Developments
Table 130. Zhongshan Sinobioway Hygene Biomedicine Corporation Information
Table 131. Zhongshan Sinobioway Hygene Biomedicine Description and Major Businesses
Table 132. Zhongshan Sinobioway Hygene Biomedicine Product Models, Descriptions and Specifications
Table 133. Zhongshan Sinobioway Hygene Biomedicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Zhongshan Sinobioway Hygene Biomedicine Recent Developments
Table 135. Shanghai United Cell Biotechnology Corporation Information
Table 136. Shanghai United Cell Biotechnology Description and Major Businesses
Table 137. Shanghai United Cell Biotechnology Product Models, Descriptions and Specifications
Table 138. Shanghai United Cell Biotechnology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. Shanghai United Cell Biotechnology Recent Developments
Table 140. Changchun GeneScience Pharmaceutical Corporation Information
Table 141. Changchun GeneScience Pharmaceutical Description and Major Businesses
Table 142. Changchun GeneScience Pharmaceutical Product Models, Descriptions and Specifications
Table 143. Changchun GeneScience Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Changchun GeneScience Pharmaceutical Recent Developments
Table 145. Key Raw Materials Distribution
Table 146. Raw Materials Key Suppliers
Table 147. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 148. Milestones in Production Technology Evolution
Table 149. Distributors List
Table 150. Market Trends and Market Evolution
Table 151. Market Drivers and Opportunities
Table 152. Market Challenges, Risks, and Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Long-acting Hormone Injection Product Picture
Figure 2. Global Long-acting Hormone Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Long-acting Contraceptive Injection Product Picture
Figure 4. Growth Hormone Injection Product Picture
Figure 5. Others Product Picture
Figure 6. Global Long-acting Hormone Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Others
Figure 10. Long-acting Hormone Injection Report Years Considered
Figure 11. Global Long-acting Hormone Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 13. Global Long-acting Hormone Injection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Long-acting Hormone Injection Revenue Market Share by Region (2020-2031)
Figure 15. Global Long-acting Hormone Injection Sales (2020-2031) & (K Units)
Figure 16. Global Long-acting Hormone Injection Sales (CAGR) by Region (2020-2031) (K Units)
Figure 17. Global Long-acting Hormone Injection Sales Market Share by Region (2020-2031)
Figure 18. Top 5 and Top 10 Manufacturers Long-acting Hormone Injection Sales Volume Market Share in 2024
Figure 19. Global Long-acting Hormone Injection Revenue Market Share Ranking (2024)
Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 21. Long-acting Contraceptive Injection Revenue Market Share by Manufacturer in 2024
Figure 22. Growth Hormone Injection Revenue Market Share by Manufacturer in 2024
Figure 23. Others Revenue Market Share by Manufacturer in 2024
Figure 24. Global Long-acting Hormone Injection Sales Market Share by Type (2020-2031)
Figure 25. Global Long-acting Hormone Injection Revenue Market Share by Type (2020-2031)
Figure 26. Global Long-acting Hormone Injection Sales Market Share by Application (2020-2031)
Figure 27. Global Long-acting Hormone Injection Revenue Market Share by Application (2020-2031)
Figure 28. North America Long-acting Hormone Injection Sales YoY (2020-2031) & (K Units)
Figure 29. North America Long-acting Hormone Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 30. North America Top 5 Manufacturers Long-acting Hormone Injection Sales Revenue (US$ Million) in 2024
Figure 31. North America Long-acting Hormone Injection Sales Volume (K Units) by Type (2020- 2031)
Figure 32. North America Long-acting Hormone Injection Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 33. North America Long-acting Hormone Injection Sales Volume (K Units) by Application (2020-2031)
Figure 34. North America Long-acting Hormone Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 35. US Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 36. Canada Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 37. Mexico Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 38. Europe Long-acting Hormone Injection Sales YoY (2020-2031) & (K Units)
Figure 39. Europe Long-acting Hormone Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 40. Europe Top 5 Manufacturers Long-acting Hormone Injection Sales Revenue (US$ Million) in 2024
Figure 41. Europe Long-acting Hormone Injection Sales Volume (K Units) by Type (2020-2031)
Figure 42. Europe Long-acting Hormone Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 43. Europe Long-acting Hormone Injection Sales Volume (K Units) by Application (2020-2031)
Figure 44. Europe Long-acting Hormone Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 45. Germany Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 46. France Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 47. U.K. Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 48. Italy Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 49. Russia Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Long-acting Hormone Injection Sales YoY (2020-2031) & (K Units)
Figure 51. Asia-Pacific Long-acting Hormone Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 52. Asia-Pacific Top 8 Manufacturers Long-acting Hormone Injection Sales Revenue (US$ Million) in 2024
Figure 53. Asia-Pacific Long-acting Hormone Injection Sales Volume (K Units) by Type (2020- 2031)
Figure 54. Asia-Pacific Long-acting Hormone Injection Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 55. Asia-Pacific Long-acting Hormone Injection Sales Volume (K Units) by Application (2020-2031)
Figure 56. Asia-Pacific Long-acting Hormone Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 57. Indonesia Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 58. Japan Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 59. South Korea Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 60. China Taiwan Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 61. India Long-acting Hormone Injection Revenue (2020-2031) & (US$ Million)
Figure 62. Central and South America Long-acting Hormone Injection Sales YoY (2020-2031) & (K Units)
Figure 63. Central and South America Long-acting Hormone Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 64. Central and South America Top 5 Manufacturers Long-acting Hormone Injection Sales Revenue (US$ Million) in 2024
Figure 65. Central and South America Long-acting Hormone Injection Sales Volume (K Units) by Type (2021-2031)
Figure 66. Central and South America Long-acting Hormone Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 67. Central and South America Long-acting Hormone Injection Sales Volume (K Units) by Application (2020-2031)
Figure 68. Central and South America Long-acting Hormone Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 69. Brazil Long-acting Hormone Injection Revenue (2020-2025) & (US$ Million)
Figure 70. Argentina Long-acting Hormone Injection Revenue (2020-2025) & (US$ Million)
Figure 71. Middle East, and Africa Long-acting Hormone Injection Sales YoY (2020-2031) & (K Units)
Figure 72. Middle East and Africa Long-acting Hormone Injection Revenue YoY (2020-2031) & (US$ Million)
Figure 73. Middle East and Africa Top 5 Manufacturers Long-acting Hormone Injection Sales Revenue (US$ Million) in 2024
Figure 74. Middle East and Africa Long-acting Hormone Injection Sales Volume (K Units) by Type (2021-2031)
Figure 75. South America Long-acting Hormone Injection Sales Revenue (US$ Million) by Type (2020-2031)
Figure 76. Middle East and Africa Long-acting Hormone Injection Sales Volume (K Units) by Application (2020-2031)
Figure 77. Middle East and Africa Long-acting Hormone Injection Sales Revenue (US$ Million) by Application (2020-2031)
Figure 78. GCC Countries Long-acting Hormone Injection Revenue (2020-2025) & (US$ Million)
Figure 79. Turkey Long-acting Hormone Injection Revenue (2020-2025) & (US$ Million)
Figure 80. Egypt Long-acting Hormone Injection Revenue (2020-2025) & (US$ Million)
Figure 81. South Africa Long-acting Hormone Injection Revenue (2020-2025) & (US$ Million)
Figure 82. Long-acting Hormone Injection Industry Chain Mapping
Figure 83. Regional Long-acting Hormone Injection Manufacturing Base Distribution (%)
Figure 84. Global Long-acting Hormone Injection Production Market Share by Region (2020-2031)
Figure 85. Long-acting Hormone Injection Production Process
Figure 86. Regional Long-acting Hormone Injection Production Cost Structure
Figure 87. Channels of Distribution (Direct Vs Distribution)
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
